FDA NDC Directory · JSON-LD · Markdown

Cymbalta

NDC 0002-3240 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Generic nameDuloxetine hydrochloride
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA021427
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsDULOXETINE HYDROCHLORIDE (30 mg/1)
Marketing started20040824
Marketing ended20261002
Package count0

External sources

Source: openFDA. Public-domain (CC0).